Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan

Balkan Med J · 2023 · PMC9998828 · PMID 36804217

Europe PMC DOI

hedged sentence

0.0950

closest p · 1.9× alpha

0.0950

boldest claim

The sentences

did not reach statistical significancep = 0.095so close (0.05 < p ≤ 0.1)

HSCT with TBI was also significantly related to secondary malignancies (adjusted HR 1.419; 95% CI, 1.104-1.823; p = 0.006; Table 4 ), whereas HSCT without TBI did not reach statistical significance (adjusted HR 1.577; 95% CI, 0.924-2.693; p = 0.095; Table 4 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.